Biosynex Statistics

Total Valuation

Biosynex has a market cap or net worth of EUR 23.25 million. The enterprise value is 76.10 million.

Market Cap	23.25M
Enterprise Value	76.10M

Important Dates

The last earnings date was Wednesday, April 23, 2025.

Earnings Date	Apr 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Biosynex has 18.75 million shares outstanding. The number of shares has increased by 0.41% in one year.

Current Share Class	18.75M
Shares Outstanding	18.75M
Shares Change (YoY)	+0.41%
Shares Change (QoQ)	-6.05%
Owned by Insiders (%)	5.70%
Owned by Institutions (%)	n/a
Float	8.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.23
PB Ratio	0.29
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.76
EV / Sales	0.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.09

Financial Position

The company has a current ratio of 0.76, with a Debt / Equity ratio of 0.78.

Current Ratio	0.76
Quick Ratio	0.27
Debt / Equity	0.78
Debt / EBITDA	n/a
Debt / FCF	-4.19
Interest Coverage	-9.31

Financial Efficiency

Return on equity (ROE) is -42.38% and return on invested capital (ROIC) is -10.32%.

Return on Equity (ROE)	-42.38%
Return on Assets (ROA)	-7.89%
Return on Invested Capital (ROIC)	-10.32%
Return on Capital Employed (ROCE)	-24.94%
Revenue Per Employee	212,536
Profits Per Employee	-91,034
Employee Count	569
Asset Turnover	0.46
Inventory Turnover	1.23

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.65% in the last 52 weeks. The beta is 0.27, so Biosynex's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	-62.65%
50-Day Moving Average	1.45
200-Day Moving Average	2.22
Relative Strength Index (RSI)	35.36
Average Volume (20 Days)	10,714

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biosynex had revenue of EUR 101.17 million and -43.33 million in losses. Loss per share was -4.03.

Revenue	101.17M
Gross Profit	57.42M
Operating Income	-27.53M
Pretax Income	-44.75M
Net Income	-43.33M
EBITDA	-22.16M
EBIT	-27.53M
Loss Per Share	-4.03

Full Income Statement

Balance Sheet

The company has 9.69 million in cash and 62.63 million in debt, giving a net cash position of -52.94 million or -2.82 per share.

Cash & Cash Equivalents	9.69M
Total Debt	62.63M
Net Cash	-52.94M
Net Cash Per Share	-2.82
Equity (Book Value)	80.50M
Book Value Per Share	7.49
Working Capital	-19.90M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.12 million and capital expenditures -4.84 million, giving a free cash flow of -14.96 million.

Operating Cash Flow	-10.12M
Capital Expenditures	-4.84M
Free Cash Flow	-14.96M
FCF Per Share	-0.80

Full Cash Flow Statement

Margins

Gross margin is 56.76%, with operating and profit margins of -27.22% and -42.83%.

Gross Margin	56.76%
Operating Margin	-27.22%
Pretax Margin	-44.23%
Profit Margin	-42.83%
EBITDA Margin	-21.90%
EBIT Margin	-27.22%
FCF Margin	n/a

Dividends & Yields

Biosynex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.41%
Shareholder Yield	-0.41%
Earnings Yield	-186.39%
FCF Yield	-64.36%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biosynex has an Altman Z-Score of 0.71. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.71
Piotroski F-Score	n/a